We are on a mission to unlock the power of personalized medicine for animals with cancer, so that pets and their families can live longer, healthier lives together.
Location: United States
Employees: 11-50
Phone: +1 650-521-0165
Total raised: $35M
Founded date: 2017
Investors 7
| Date | Name | Website |
| - | BonAngels ... | bonangels.... |
| - | Transition... | t1st.vc |
| - | BASS Inves... | bass.vc |
| 30.09.2022 | Primer Saz... | primersazz... |
| - | Blue Bear ... | bbv.io/ |
| - | Draper Ass... | draper.vc |
| - | StartX | startx.com |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 21.12.2023 | Series A | $23M | - |
| 15.04.2021 | Series A | $8M | - |
| 15.04.2019 | - | $4M | - |
Mentions in press and media 17
| Date | Title | Description |
| 18.09.2026 | NAVER D2SF Invests in AI-Driven Precision Medicine Company ImpriMed | ImpriMed combines ex vivo functional testing with multimodal AI to support personalized cancer treatment decisions and drug development The investment is part of ImpriMed's $10 million Series A2 bridge round as the company advances U.S. com... |
| 21.12.2023 | ImpriMed: Precision Medicine Company Secures $23 Million To Improve Cancer Treatment | ImpriMed – a leading precision medicine startup focused on utilizing AI to improve cancer treatment, recently announced the close of a $23 million Series A funding round, led by SBVA. And HRZ Han River Partners, SK Telecom, KDB Silicon Vall... |
| 19.12.2023 | ImpriMed Closes $23M Series A Financing | MOUNTAIN VIEW, CA, ImpriMed today announced the close of a $23 million Series A funding round. >> Click here for more funding data on ImpriMed >> To export ImpriMed funding data to PDF and Excel, click here ImpriMed, a le... |
| 19.12.2023 | Dog cancer treatment ImpriMed aims to expand its AI technology into human oncology | ImpriMed, a California-based precision medicine startup, builds AI-powered dog cancer treatment technology that helps veterinarians identify the most suitable drugs for individual canine and feline blood cancers. The startup, which centers ... |
| 19.12.2023 | ImpriMed Raises $23M in Series A Funding | ImpriMed, a Mountain View, CA-based precision medicine startup focused on leveraging artificial intelligence to improve cancer treatment, raised $23M in Series A funding. The round was led by SBVA. HRZ Han River Partners, SK Telecom, KDB Si... |
| 05.10.2022 | ImpriMed Wins Place at the Mayo Clinic Platform_Accelerate Immersive Program | EAST PALO ALT, CALIFORNIA, UNITED STATES, October 5, 2022 /EINPresswire.com/ -- ImpriMed, Inc., a leading veterinary precision medicine startup, is pleased to announce their inclusion in Mayo Clinic Platform_Accelerate, an immersive 20-week... |
| 13.06.2022 | 40 Under 40 in Cancer Class of 2022 Recognizes Dr. Sungwon Lim, ImpriMed CEO & Co-Founder | PALO ALTO, CA, UNITED STATES, June 13, 2022 /EINPresswire.com/ -- ImpriMed, Inc., a leading veterinary oncology precision medicine startup, is pleased to announce that their CEO and Co-Founder is a recipient of the 40 Under 40 in Cancer Awa... |
| 02.05.2022 | ImpriMed Presents New Research Findings at The Veterinary Cancer Society (VCS) Mid-Year Conference | PALO ALTO, CA, UNITED STATES, May 2, 2022 /EINPresswire.com/ -- Palo Alto, CA - ImpriMed, Inc., a leading veterinary precision medicine startup, is pleased to announce their latest data was selected by the Veterinary Cancer Society Executiv... |
| 21.03.2022 | ImpriMed AI and machine learning is disrupting the veterinary oncology tools available for better treatment outcomes | PALO ALTO, CA, UNITED STATES, March 21, 2022 /EINPresswire.com/ -- ImpriMed, Inc., a leading veterinary precision medicine startup, is pleased to announce that their second paper, “Predicting Dynamic Clinical Outcomes of Chemotherapy for Ca... |
| 18.11.2021 | Primer Sazze Partners closes $127M second fund aimed at South Korean entrepreneurs | Primer Sazze Partners, a San Jose-based venture capital firm, announced today it has raised its second fund at $127 million (150 billion won) to invest in startups founded by Korean entrepreneurs in Asia and North America. South Korea-based... |
Show more